GBS-OP(+) (n = 29) | p Value | |||
Group 1 | Group 2 | Group 3 | ||
(n = 9) | (n = 10) | (n = 10) | ||
Age; mean (95% CI), years | 45.1 (29.4 to 60.8) | 41.0 (29.9 to 52.2) | 36.5 (24.0 to 49.0) | 0.582 |
Gender (male/female); n | 4/5 | 5/5 | 6/4 | 0.897 |
Antecedent infection; n (%) | ||||
Respiratory | 5 (56) | 8 (80) | 5 (50) | 0.400 |
Gastrointestinal | 4 (44) | 2 (20) | 5 (50) | 0.400 |
Ataxia; n (%) | 9 (100) | 8 (80) | 3 (30) | 0.003* |
Cranial nerve deficits; n (%) | ||||
VII | 5 (56) | 6 (60) | 6 (60) | 1 |
IX, X | 7 (78) | 4 (40) | 8 (80) | 0.181 |
Sensory disturbances; n (%) | 9 (100) | 9 (90) | 9 (90) | 1 |
Superficial | 8 (89) | 8 (80) | 9 (90) | 1 |
Deep | 8 (89) | 2 (20) | 3 (30) | 0.005† |
Mechanical ventilation; n (%) | 3 (33) | 2 (20) | 2 (20) | 0.751 |
*Group 3 vs Group 1, p = 0.003: Group 3 vs Group 2, p = 0.070.
†Group 2 vs Group 1, odds ratio (OR) 0.031 (95% confidence intervals (CI) 0.002 to 0.418); Group 2 vs Group 3, OR 0.583 (95% CI 0.075 to 4.562); Group 1 vs Group 3, OR 18.67 (95% CI 1.56 to 222.93).
GBS-OP(+), Guillain–Barré syndrome with ophthalmoplegia.